Jason L Groves

Insider

First SEC filing: June 8, 2026 · Latest: June 8, 2026

On this page

Insider at Companies where this person is a reporting insider.
Insider transactions Every share this person bought or sold, from Form 4 filings.
Derivatives Options and other derivative holdings reported by this person.
Compensation Executive pay disclosed in company proxy statements.

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 17 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

17 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
June 8, 2026	MTVA	A	17,186	—	—	21,338 Direct	+413.92%	Acquired	(price as of 2026-08-21)
June 30, 2025	MTVA	A	28,147	—	—	45,699 Direct	+160.36%	Acquired	(price as of 2026-08-21)
June 7, 2024	MTVA	A	5,051	—	—	17,552 Direct	+40.40%	Acquired	(price as of 2026-08-21)
July 27, 2023	MTVA	A	12,500	—	—	100,000 Direct	+14.29%	Acquired	(price as of 2026-08-21)
July 27, 2023	MTVA	A	87,500	—	—	87,500 Direct	—	Acquired	(price as of 2026-08-21)
June 9, 2022	MTVA	A	20,000	—	—	20,000 Direct	—	Acquired	(price as of 2026-08-21)
Feb. 17, 2015	MED	A	2,000	—	—	6,000 Direct	+50.00%	Acquired	(price as of 2026-08-21)
Feb. 17, 2015	MED	A	1,250	—	—	21,697 Direct	+6.11%	Acquired	(price as of 2026-08-21)
Jan. 2, 2015	MED	F	2,000	$32.24	$64,480	20,447 Direct	-8.91%	Disposed	-63.5% (price as of 2026-08-21)
June 10, 2014	MED	S	3,250	$31.75	$103,188	22,447 Direct	-12.65%	Disposed	-63.0% (price as of 2026-08-21)
June 4, 2014	MED	F	1,750	$30.73	$53,778	25,697 Direct	-6.38%	Disposed	-61.7% (price as of 2026-08-21)
April 7, 2014	MED	F	657	$30.54	$20,065	27,447 Direct	-2.34%	Disposed	-61.5% (price as of 2026-08-21)
Feb. 5, 2014	MED	A	1,875	—	—	28,104 Direct	+7.15%	Acquired	(price as of 2026-08-21)
Feb. 5, 2014	MED	A	2,000	—	—	4,000 Direct	+100.00%	Acquired	(price as of 2026-08-21)
Feb. 19, 2013	MED	A	2,000	—	—	2,000 Direct	—	Acquired	(price as of 2026-08-21)
Jan. 2, 2013	MED	A	25,000	—	—	26,229 Direct	+2034.17%	Acquired	(price as of 2026-08-21)
June 20, 2011	MED	A	946	$22.40	$21,190	1,229 Direct	+334.28%	Acquired	-47.5% (price as of 2026-08-21)
April 6, 2010	MED	A	283	$26.52	$7,505	283 Direct	—	Acquired	-55.7% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
June 9, 2022	MTVA	Nonstatutory Stock Option (right to buy)	Common Stock (20,000)	$0.47	June 9, 2032	20,000	Acquired
Feb. 17, 2015	MED	Stock Options	Common Stock (2,000)	$31.55	Feb. 17, 2025	2,000	Acquired
Feb. 5, 2014	MED	Stock Options	Common Stock (2,000)	$26.52	Feb. 5, 2024	2,000	Acquired
Feb. 19, 2013	MED	Stock Options	Common Stock (2,000)	$24.26	Feb. 19, 2023	2,000	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

MED

Chief Legal Officer & Corporate Secretary

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2025	$427,781	—	$568,465	—	$149,723	—	$14,483	$1,160,452
2024	$427,781	—	$505,934	—	$146,729	—	$14,349	$1,094,793
2023	$427,781	—	$805,133	—	$344,364	—	$54,866	$1,632,143

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.